Clinical and Angiographic Outcomes in Diabetics From the ENDEAVOR IV Trial
Authors:
- Martin B. LeonMLMartin B. Leon
- 1 October 2009
- journal article
- research article
- Published by Elsevier in JACC: Cardiovascular Interventions
- Vol. 2 (10) , 967-976
Abstract
No abstract availableKeywords
Funding Information
- Medtronic
This publication has 18 references indexed in Scilit:
- Drug-Eluting or Bare-Metal Stenting in Patients With Diabetes MellitusCirculation, 2008
- Drug eluting and bare metal stents in people with and without diabetes: collaborative network meta-analysisBMJ, 2008
- Balancing the Risks of Restenosis and Stent Thrombosis in Bare-Metal Versus Drug-Eluting StentsJACC, 2008
- Two-Year Clinical Outcomes With Drug-Eluting Stents for Diabetic Patients With De Novo Coronary LesionsCirculation, 2008
- One-Year Results of the SCORPIUS StudyJACC, 2007
- Clinical End Points in Coronary Stent TrialsCirculation, 2007
- Effect of Diabetes Mellitus on Five-Year Clinical Outcomes After Single-Vessel Coronary Stenting (a Pooled Analysis of Coronary Stent Clinical Trials)The American Journal of Cardiology, 2006
- Impact of Routine Angiographic Follow-Up on the Clinical Benefits of Paclitaxel-Eluting StentsJACC, 2006
- The long-term value of sirolimus- and paclitaxel-eluting stents over bare metal stents in patients with diabetes mellitusEuropean Heart Journal, 2006
- Beyond RestenosisCirculation, 2004